Dietary intake of sulfur amino acids and risk of kwashiorkor malnutrition in eastern Democratic Republic of the Congo.
Amino Acids, Sulfur
/ administration & dosage
Child Nutrition Disorders
/ epidemiology
Child, Preschool
Cross-Sectional Studies
Democratic Republic of the Congo
/ epidemiology
Diet
Diet Surveys
Dietary Proteins
/ chemistry
Feeding Behavior
Humans
Kwashiorkor
/ epidemiology
Manihot
/ chemistry
Methionine
/ administration & dosage
Nutritional Status
Risk Factors
Severe Acute Malnutrition
24-h recall
Congo
cysteine
diet
edematous malnutrition
kwashiorkor
methionine
protein
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
received:
24
11
2020
accepted:
01
04
2021
pubmed:
9
5
2021
medline:
17
7
2022
entrez:
8
5
2021
Statut:
ppublish
Résumé
Kwashiorkor is an often-fatal type of severe acute malnutrition affecting hundreds of thousands of children annually, but whose etiology is still unknown. Evidence suggests inadequate sulfur amino acid (SAA) status may explain many signs of the condition but studies evaluating dietary protein intake in relation to the genesis of kwashiorkor have been conflicting. We know of no studies of kwashiorkor that have measured dietary SAAs. We aimed to determine whether children in a population previously determined to have high prevalence of kwashiorkor [high-prevalence population (HPP)] have lower dietary intakes of SAAs than children in a low-prevalence population (LPP). A cross-sectional census survey design of 358 children compared 2 previously identified adjacent populations of children 36-59 mo old in North Kivu Province of the Democratic Republic of the Congo. Data collected included urinary thiocyanate (SCN), cyanogens in cassava-based food products, recent history of illness, and a 24-h quantitative diet recall for the child. The HPP and LPP had kwashiorkor prevalence of 4.5% and 1.7%, respectively. A total of 170 children from 141 households in the LPP and 169 children from 138 households in the HPP completed the study. A higher proportion of HPP children had measurable urinary SCN (44.8% compared with 29.4%, P < 0.01). LPP children were less likely to have been ill recently (26.8% compared with 13.6%, P < 0.01). Median [IQR] intake of SAAs was 32.4 [22.9-49.3] mg/kg for the LPP and 29.6 [18.1-44.3] mg/kg for the HPP (P < 0.05). Methionine was the first limiting amino acid in both populations, with the highest risk of inadequate intake found among HPP children (35.1% compared with 23.6%, P < 0.05). Children in a population with a higher prevalence of kwashiorkor have lower dietary intake of SAAs than children in a population with a lower prevalence. Trial interventions to reduce incidence of kwashiorkor should consider increasing SAA intake, paying particular attention to methionine.
Sections du résumé
BACKGROUND
Kwashiorkor is an often-fatal type of severe acute malnutrition affecting hundreds of thousands of children annually, but whose etiology is still unknown. Evidence suggests inadequate sulfur amino acid (SAA) status may explain many signs of the condition but studies evaluating dietary protein intake in relation to the genesis of kwashiorkor have been conflicting. We know of no studies of kwashiorkor that have measured dietary SAAs.
OBJECTIVES
We aimed to determine whether children in a population previously determined to have high prevalence of kwashiorkor [high-prevalence population (HPP)] have lower dietary intakes of SAAs than children in a low-prevalence population (LPP).
METHODS
A cross-sectional census survey design of 358 children compared 2 previously identified adjacent populations of children 36-59 mo old in North Kivu Province of the Democratic Republic of the Congo. Data collected included urinary thiocyanate (SCN), cyanogens in cassava-based food products, recent history of illness, and a 24-h quantitative diet recall for the child.
RESULTS
The HPP and LPP had kwashiorkor prevalence of 4.5% and 1.7%, respectively. A total of 170 children from 141 households in the LPP and 169 children from 138 households in the HPP completed the study. A higher proportion of HPP children had measurable urinary SCN (44.8% compared with 29.4%, P < 0.01). LPP children were less likely to have been ill recently (26.8% compared with 13.6%, P < 0.01). Median [IQR] intake of SAAs was 32.4 [22.9-49.3] mg/kg for the LPP and 29.6 [18.1-44.3] mg/kg for the HPP (P < 0.05). Methionine was the first limiting amino acid in both populations, with the highest risk of inadequate intake found among HPP children (35.1% compared with 23.6%, P < 0.05).
CONCLUSIONS
Children in a population with a higher prevalence of kwashiorkor have lower dietary intake of SAAs than children in a population with a lower prevalence. Trial interventions to reduce incidence of kwashiorkor should consider increasing SAA intake, paying particular attention to methionine.
Identifiants
pubmed: 33963736
pii: S0002-9165(22)00417-8
doi: 10.1093/ajcn/nqab136
pmc: PMC8435999
doi:
Substances chimiques
Amino Acids, Sulfur
0
Dietary Proteins
0
Methionine
AE28F7PNPL
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
925-933Subventions
Organisme : NIH HHS
ID : K24 DK104676
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
J Nutr. 1981 Nov;111(11):1928-36
pubmed: 6795323
J Biol Chem. 2010 Jun 11;285(24):18528-36
pubmed: 20395294
Bull World Health Organ. 1952;5(1):1-71
pubmed: 14925815
RNA Biol. 2016 Sep;13(9):810-9
pubmed: 27322343
Nutr Res Rev. 2009 Dec;22(2):175-87
pubmed: 19835653
J Pediatr Gastroenterol Nutr. 1995 Aug;21(2):130-6
pubmed: 7472897
Animal. 2012 Apr;6(4):586-93
pubmed: 22436274
Plant Foods Hum Nutr. 1999;54(4):327-36
pubmed: 10798343
Pediatrics. 1975 Jul;56(1):152
pubmed: 807905
Ann Trop Paediatr. 2000 Mar;20(1):34-40
pubmed: 10824211
Food Nutr Bull. 2010 Mar;31(1):34-41
pubmed: 20461902
Food Chem Toxicol. 2011 Mar;49(3):631-5
pubmed: 20654676
Toxicol Sci. 1999 Aug;50(2):228-35
pubmed: 10478859
J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):487-93
pubmed: 17414147
Food Chem Toxicol. 2002 Jul;40(7):1001-5
pubmed: 12065222
J Pediatr. 2000 Sep;137(3):421-4
pubmed: 10969271
J Nutr. 2006 Oct;136(10):2594-9
pubmed: 16988132
Amino Acids. 2016 Dec;48(12):2821-2830
pubmed: 27562792
Am J Clin Nutr. 1965 Jul;17:11-4
pubmed: 14322831
Am J Clin Nutr. 2009 Feb;89(2):592-600
pubmed: 19116330
Ann Trop Paediatr. 1995 Sep;15(3):221-6
pubmed: 8534041
BMJ. 2005 May 14;330(7500):1109
pubmed: 15851401
FAO Food Nutr Pap. 2013;92:1-66
pubmed: 26369006
J Nutr. 1992 Mar;122(3):420-7
pubmed: 1542000
PeerJ. 2014 Apr 15;2:e350
pubmed: 24765584
Br J Anaesth. 2012 Mar;108(3):384-94
pubmed: 22290457
Am J Clin Nutr. 2005 Oct;82(4):792-800
pubmed: 16210708
Indian J Med Res. 1955 Oct;43(4):751-73
pubmed: 13278045
Food Nutr Bull. 2018 Dec;39(4):512-520
pubmed: 30136596
Am J Clin Nutr. 1964 Jun;14:313-9
pubmed: 14168978
Am J Clin Nutr. 2006 Dec;84(6):1393-9
pubmed: 17158422
Am J Clin Nutr. 2002 Sep;76(3):646-52
pubmed: 12198013
Nutr Res Rev. 1993 Jan;6(1):121-35
pubmed: 19094305
J Anim Sci. 2010 Aug;88(8):2674-83
pubmed: 20407072
Lancet. 1963 Dec 28;2(7322):1342-8
pubmed: 14071147
Food Chem Toxicol. 2012 May;50(5):1517-23
pubmed: 22342647
Plant Foods Hum Nutr. 1998;52(2):151-60
pubmed: 9839814
Clin Chem. 1999 Sep;45(9):1459-64
pubmed: 10471648
Nutr Rev. 2012 Mar;70(3):176-87
pubmed: 22364160
J Nutr. 1988 Jul;118(7):877-82
pubmed: 3392598
Ann Trop Paediatr. 1987 Mar;7(1):1-5
pubmed: 2438995
Pediatrics. 1966 Oct;38(4):605-12
pubmed: 5922176
FASEB J. 2009 Feb;23(2):464-72
pubmed: 18845767
Am J Physiol. 1988 Sep;255(3 Pt 1):E322-31
pubmed: 3421329
Nutr Metab (Lond). 2007 Nov 06;4:24
pubmed: 17986345
Microcirculation. 2008 May;15(4):283-96
pubmed: 18464158
Matern Child Nutr. 2006 Apr;2(2):114-22
pubmed: 16881921
Br Med J. 1952 Oct 11;2(4788):796-8
pubmed: 12978334